Challenges in developing evidence-based recommendations using the grade approach: The case of mental, neurological, and substance use disorders

PLoS Medicine

Volumn 7, Issue 8, 2010, Pages

  Barbui, Corrado ^a   Dua, Tarun ^b   van Ommeren, Mark ^b   Yasamy, M Taghi ^b   Fleischmann, Alexandra ^b   Clark, Nicolas ^b   Thornicroft, Graham ^c   Hill, Suzanne ^b   Saxena, Shekhar ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL RESEARCH; DATA ANALYSIS; EVIDENCE BASED MEDICINE; FEASIBILITY STUDY; HEALTH CARE PLANNING; INTERNAL CONSISTENCY; MENTAL DISEASE; METHODOLOGY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PUBLIC HEALTH; PUBLISHING; QUALITY CONTROL; RELIABILITY; REPRODUCIBILITY; SOCIOECONOMICS; SUBSTANCE ABUSE; WORLD HEALTH ORGANIZATION;

EVALUATION STUDIES AS TOPIC; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HUMANS; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; SUBSTANCE-RELATED DISORDERS;

EID: 77956798216     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000322     Document Type: Article

References (26)

1. McCarthy M (2005) Critics slam draft WHO report on homoeopathy. Lancet 366: 705-706.
2. Horton R (2002) WHO: the casualties and compromises of renewal. Lancet 359: 1605-1611.
3. Oxman AD, Lavis JN, Fretheim A (2007) Use of evidence in WHO recommendations. Lancet 369: 1883-1889.
4. Hill S, Pang T (2007) Leading by example: a culture change at WHO. Lancet 369: 1842-1844.
5. World Health Organization (2008) WHO Handbook for guideline development. Available: http:// www.searo.who.int/LinkFiles/RPC_Handbook_Guideline_Development.pdf. Accessed 29 July 2010.
6. Schunemann HJ, Hill SR, Kakad M, Vist GE, Bellamy R, et al. (2007) Transparent development of the WHO rapid advice guidelines. PLoS Med 4: e119. doi:10.1371/journal.pmed.0040119.
7. Schunemann HJ, Hill SR, Kakad M, Bellamy R, Uyeki TM, et al. (2007) WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 7: 21-31.
8. World Health Organization (2009) Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva: WHO.
9. World Health Organization. Scaling up care for mental, neurological, and substance use disorders. Available: http://www.who.int/mental_health/ mhgap_final_english.pdf. Accessed Accessed 29 July 2010.
10. Patel V, Thornicroft G (2009) Packages of care for mental, neurological, and substance use disorders in low- and middle-income countries: PLoS Medicine Series. PLoS Med 6: e1000160. doi:10.1371/journal.pmed.1000160.
11. Haynes R (2006) Forming research questions. In Clinical epidemiology: how to do clinical practice research. Haynes R, Sacket D, Guyatt G, Tugwell P, eds. Philadelphia: Lippincott Williams & Wilkins. pp 3-14.
12. Kavanagh BP (2009) The GRADE system for rating clinical guidelines. PLoS Med 6: e1000094. doi:10.1371/journal.pmed.1000094.
13. Ioannidis JP, Trikalinos TA (2007) The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ 176: 1091-1096.
14. Moreno SG, Sutton AJ, Turner EH, Abrams KR, Cooper NJ, et al. (2009) Novel methods to deal with publication biases: secondary analysis of antide-pressant trials in the FDA trial registry database and related journal publications. BMJ 339: b2981.
15. Sackett DL, Wennberg JE (1997) Choosing the best research design for each question. BMJ 315: 1636.
16. Guyatt GH, Oxman AD, Kunz R, Jaeschke R, Helfand M, et al. (2008) Incorporating considerations of resources use into grading recommendations. BMJ 336: 1170-1173.
17. Guyatt GH, Oxman AD, Kunz R, Falck-Ytter Y, Vist GE, et al. (2008) Going from evidence to recommendations. BMJ 336: 1049-1051.
18. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, et al. (2008) What is "quality of evidence" and why is it important to clinicians? BMJ 336: 995-998.
19. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, et al. (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336: 924-926.
20. Bolton P, Bass J, Neugebauer R, Verdeli H, Clougherty KF, et al. (2003) Group interpersonal psychotherapy for depression in rural Uganda: a randomized controlled trial. JAMA 289: 3117-3124.
21. Rahman A (2007) Challenges and opportunities in developing a psychological intervention for perinatal depression in rural Pakistan-a multi-method study. Arch Womens Ment Health 10: 211-219.
22. Rahman A, Malik A, Sikander S, Roberts C, Creed F (2008) Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial. Lancet 372: 902-909.
23. Ansari MT, Tsertsvadze A, Moher D (2009) Grading quality of evidence and strength of recommendations: a perspective. PLoS Med 6: e1000151. doi:10.1371/journal.pmed.1000151.
24. Desjarlais R, Eisenberg L, Good B (1995) World mental health: problems and priorities in low-income countries. New York: Oxford University Press.
25. Institute of Medicine (2001) Neurological, psychiatric, and developmental disorders: meeting the challenge in the developing world. Washington (D.C.): National Academy Press.
26. WHO (2001) The world health report 2001. Mental health: new understanding, new hope. Geneva: World Health Organization, Available: http://www.who.int/whr/2001/main/en/. Accessed 29 July 2010.